Phyllodes tumor in a patient with a preexistent fibrocystic disease

Gynecol Obstet Invest. 1992;34(1):61-4. doi: 10.1159/000292727.

Abstract

A phyllodes tumor appeared at the site of a resected fibrocystic disease focus. Administration of danazol resulted in temporary regression, but the tumor resumed growth. Relative hyperestrogenism also continued to increase in spite of continued long-term administration of danazol. After 12 months a simple mastectomy was performed. Most of the resected mass consisted of the phyllodes tumor, but it also contained fibrocystic disease.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Breast Neoplasms / pathology*
  • Breast Neoplasms / therapy
  • Combined Modality Therapy
  • Danazol / therapeutic use
  • Female
  • Fibrocystic Breast Disease / complications
  • Fibrocystic Breast Disease / pathology*
  • Humans
  • Mastectomy, Simple
  • Neoplasm Recurrence, Local
  • Phyllodes Tumor / pathology*
  • Phyllodes Tumor / therapy

Substances

  • Danazol